Skip to main content
. 2022 Oct 19;10(10):2635. doi: 10.3390/biomedicines10102635

Figure 3.

Figure 3

Evolution of number of annual clinically relevant asthma exacerbations before and after 52-week treatment with mepolizumab 100 mg every 4 weeks. Asterisks indicate statistical significance (**** p < 0.001).